 | • レポートコード：MRC2-11QY13906 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、145ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は肺炎球菌ワクチンのグローバル市場について調査・分析したレポートです。種類別（PPSV23、PCV7/13、PCV10）市場規模、用途別（乳幼児用、子供用（2-10）、人用（10-64）、老人用（65歳以上））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別肺炎球菌ワクチンの競争状況、市場シェア ・世界の肺炎球菌ワクチン市場：種類別市場規模 2015年-2020年（PPSV23、PCV7/13、PCV10） ・世界の肺炎球菌ワクチン市場：種類別市場規模予測 2021年-2026年（PPSV23、PCV7/13、PCV10） ・世界の肺炎球菌ワクチン市場：用途別市場規模 2015年-2020年（乳幼児用、子供用（2-10）、人用（10-64）、老人用（65歳以上）） ・世界の肺炎球菌ワクチン市場：用途別市場規模予測 2021年-2026年（乳幼児用、子供用（2-10）、人用（10-64）、老人用（65歳以上）） ・北米の肺炎球菌ワクチン市場分析：米国、カナダ ・ヨーロッパの肺炎球菌ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの肺炎球菌ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の肺炎球菌ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの肺炎球菌ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Pfizer、Sanofi、GSK、Merck、Eli Lilly、AstraZeneca、Abera、S K Chemicals、Beijing Minhai Biotechnology、Baxter、Biken、Celgene Corporation、Panacea Biotec、Serum Institute of India、Genentech、Genocea Biosciences、ImmunoBiology、Lupin、Nuron Biotech、Biogen、Valneva Austria、Sinovac ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Pneumococcal Vaccines Market
The global Pneumococcal Vaccines market size is projected to reach US$ 7121.8 million by 2026, from US$ 7038.2 million in 2020, at a CAGR of 1.1%% during 2021-2026.
Global Pneumococcal Vaccines Scope and Market Size
Pneumococcal Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pneumococcal Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pneumococcal Vaccines market is segmented into
PPSV 23
PCV 7/13
PCV 10
Segment by Application, the Pneumococcal Vaccines market is segmented into
For Infants
For Children (2-10)
For Person (10-64)
For The Old (Above 65)
Regional and Country-level Analysis
The Pneumococcal Vaccines market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pneumococcal Vaccines market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pneumococcal Vaccines Market Share Analysis
Pneumococcal Vaccines market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pneumococcal Vaccines business, the date to enter into the Pneumococcal Vaccines market, Pneumococcal Vaccines product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Sanofi
GSK
Merck
Eli Lilly
AstraZeneca
Abera
S K Chemicals
Beijing Minhai Biotechnology
Baxter
Biken
Celgene Corporation
Panacea Biotec
Serum Institute of India
Genentech
Genocea Biosciences
ImmunoBiology
Lupin
Nuron Biotech
Biogen
Valneva Austria
Sinovac
1 Study Coverage
1.1 Pneumococcal Vaccines Product Introduction
1.2 Market Segments
1.3 Key Pneumococcal Vaccines Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pneumococcal Vaccines Market Size Growth Rate by Type
1.4.2 PPSV 23
1.4.3 PCV 7/13
1.4.4 PCV 10
1.5 Market by Application
1.5.1 Global Pneumococcal Vaccines Market Size Growth Rate by Application
1.5.2 For Infants
1.5.3 For Children (2-10)
1.5.4 For Person (10-64)
1.5.5 For The Old (Above 65)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pneumococcal Vaccines Market Size, Estimates and Forecasts
2.1.1 Global Pneumococcal Vaccines Revenue 2015-2026
2.1.2 Global Pneumococcal Vaccines Sales 2015-2026
2.2 Global Pneumococcal Vaccines, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Pneumococcal Vaccines Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pneumococcal Vaccines Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pneumococcal Vaccines Competitor Landscape by Players
3.1 Pneumococcal Vaccines Sales by Manufacturers
3.1.1 Pneumococcal Vaccines Sales by Manufacturers (2015-2020)
3.1.2 Pneumococcal Vaccines Sales Market Share by Manufacturers (2015-2020)
3.2 Pneumococcal Vaccines Revenue by Manufacturers
3.2.1 Pneumococcal Vaccines Revenue by Manufacturers (2015-2020)
3.2.2 Pneumococcal Vaccines Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pneumococcal Vaccines Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pneumococcal Vaccines Revenue in 2019
3.2.5 Global Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pneumococcal Vaccines Price by Manufacturers
3.4 Pneumococcal Vaccines Manufacturing Base Distribution, Product Types
3.4.1 Pneumococcal Vaccines Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pneumococcal Vaccines Product Type
3.4.3 Date of International Manufacturers Enter into Pneumococcal Vaccines Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pneumococcal Vaccines Market Size by Type (2015-2020)
4.1.1 Global Pneumococcal Vaccines Sales by Type (2015-2020)
4.1.2 Global Pneumococcal Vaccines Revenue by Type (2015-2020)
4.1.3 Pneumococcal Vaccines Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pneumococcal Vaccines Market Size Forecast by Type (2021-2026)
4.2.1 Global Pneumococcal Vaccines Sales Forecast by Type (2021-2026)
4.2.2 Global Pneumococcal Vaccines Revenue Forecast by Type (2021-2026)
4.2.3 Pneumococcal Vaccines Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pneumococcal Vaccines Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pneumococcal Vaccines Market Size by Application (2015-2020)
5.1.1 Global Pneumococcal Vaccines Sales by Application (2015-2020)
5.1.2 Global Pneumococcal Vaccines Revenue by Application (2015-2020)
5.1.3 Pneumococcal Vaccines Price by Application (2015-2020)
5.2 Pneumococcal Vaccines Market Size Forecast by Application (2021-2026)
5.2.1 Global Pneumococcal Vaccines Sales Forecast by Application (2021-2026)
5.2.2 Global Pneumococcal Vaccines Revenue Forecast by Application (2021-2026)
5.2.3 Global Pneumococcal Vaccines Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pneumococcal Vaccines by Country
6.1.1 North America Pneumococcal Vaccines Sales by Country
6.1.2 North America Pneumococcal Vaccines Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pneumococcal Vaccines Market Facts & Figures by Type
6.3 North America Pneumococcal Vaccines Market Facts & Figures by Application
7 Europe
7.1 Europe Pneumococcal Vaccines by Country
7.1.1 Europe Pneumococcal Vaccines Sales by Country
7.1.2 Europe Pneumococcal Vaccines Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pneumococcal Vaccines Market Facts & Figures by Type
7.3 Europe Pneumococcal Vaccines Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pneumococcal Vaccines by Region
8.1.1 Asia Pacific Pneumococcal Vaccines Sales by Region
8.1.2 Asia Pacific Pneumococcal Vaccines Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pneumococcal Vaccines Market Facts & Figures by Type
8.3 Asia Pacific Pneumococcal Vaccines Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pneumococcal Vaccines by Country
9.1.1 Latin America Pneumococcal Vaccines Sales by Country
9.1.2 Latin America Pneumococcal Vaccines Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pneumococcal Vaccines Market Facts & Figures by Type
9.3 Central & South America Pneumococcal Vaccines Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pneumococcal Vaccines by Country
10.1.1 Middle East and Africa Pneumococcal Vaccines Sales by Country
10.1.2 Middle East and Africa Pneumococcal Vaccines Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pneumococcal Vaccines Market Facts & Figures by Type
10.3 Middle East and Africa Pneumococcal Vaccines Market Facts & Figures by Application
11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Pneumococcal Vaccines Products Offered
11.1.5 Pfizer Related Developments
11.2 Sanofi
11.2.1 Sanofi Corporation Information
11.2.2 Sanofi Description and Business Overview
11.2.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Sanofi Pneumococcal Vaccines Products Offered
11.2.5 Sanofi Related Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Description and Business Overview
11.3.3 GSK Sales, Revenue and Gross Margin (2015-2020)
11.3.4 GSK Pneumococcal Vaccines Products Offered
11.3.5 GSK Related Developments
11.4 Merck
11.4.1 Merck Corporation Information
11.4.2 Merck Description and Business Overview
11.4.3 Merck Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Merck Pneumococcal Vaccines Products Offered
11.4.5 Merck Related Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Corporation Information
11.5.2 Eli Lilly Description and Business Overview
11.5.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Eli Lilly Pneumococcal Vaccines Products Offered
11.5.5 Eli Lilly Related Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Corporation Information
11.6.2 AstraZeneca Description and Business Overview
11.6.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.6.4 AstraZeneca Pneumococcal Vaccines Products Offered
11.6.5 AstraZeneca Related Developments
11.7 Abera
11.7.1 Abera Corporation Information
11.7.2 Abera Description and Business Overview
11.7.3 Abera Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Abera Pneumococcal Vaccines Products Offered
11.7.5 Abera Related Developments
11.8 S K Chemicals
11.8.1 S K Chemicals Corporation Information
11.8.2 S K Chemicals Description and Business Overview
11.8.3 S K Chemicals Sales, Revenue and Gross Margin (2015-2020)
11.8.4 S K Chemicals Pneumococcal Vaccines Products Offered
11.8.5 S K Chemicals Related Developments
11.9 Beijing Minhai Biotechnology
11.9.1 Beijing Minhai Biotechnology Corporation Information
11.9.2 Beijing Minhai Biotechnology Description and Business Overview
11.9.3 Beijing Minhai Biotechnology Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Beijing Minhai Biotechnology Pneumococcal Vaccines Products Offered
11.9.5 Beijing Minhai Biotechnology Related Developments
11.10 Baxter
11.10.1 Baxter Corporation Information
11.10.2 Baxter Description and Business Overview
11.10.3 Baxter Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Baxter Pneumococcal Vaccines Products Offered
11.10.5 Baxter Related Developments
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Description and Business Overview
11.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Pfizer Pneumococcal Vaccines Products Offered
11.1.5 Pfizer Related Developments
11.12 Celgene Corporation
11.12.1 Celgene Corporation Corporation Information
11.12.2 Celgene Corporation Description and Business Overview
11.12.3 Celgene Corporation Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Celgene Corporation Products Offered
11.12.5 Celgene Corporation Related Developments
11.13 Panacea Biotec
11.13.1 Panacea Biotec Corporation Information
11.13.2 Panacea Biotec Description and Business Overview
11.13.3 Panacea Biotec Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Panacea Biotec Products Offered
11.13.5 Panacea Biotec Related Developments
11.14 Serum Institute of India
11.14.1 Serum Institute of India Corporation Information
11.14.2 Serum Institute of India Description and Business Overview
11.14.3 Serum Institute of India Sales, Revenue and Gross Margin (2015-2020)
11.14.4 Serum Institute of India Products Offered
11.14.5 Serum Institute of India Related Developments
11.15 Genentech
11.15.1 Genentech Corporation Information
11.15.2 Genentech Description and Business Overview
11.15.3 Genentech Sales, Revenue and Gross Margin (2015-2020)
11.15.4 Genentech Products Offered
11.15.5 Genentech Related Developments
11.16 Genocea Biosciences
11.16.1 Genocea Biosciences Corporation Information
11.16.2 Genocea Biosciences Description and Business Overview
11.16.3 Genocea Biosciences Sales, Revenue and Gross Margin (2015-2020)
11.16.4 Genocea Biosciences Products Offered
11.16.5 Genocea Biosciences Related Developments
11.17 ImmunoBiology
11.17.1 ImmunoBiology Corporation Information
11.17.2 ImmunoBiology Description and Business Overview
11.17.3 ImmunoBiology Sales, Revenue and Gross Margin (2015-2020)
11.17.4 ImmunoBiology Products Offered
11.17.5 ImmunoBiology Related Developments
11.18 Lupin
11.18.1 Lupin Corporation Information
11.18.2 Lupin Description and Business Overview
11.18.3 Lupin Sales, Revenue and Gross Margin (2015-2020)
11.18.4 Lupin Products Offered
11.18.5 Lupin Related Developments
11.19 Nuron Biotech
11.19.1 Nuron Biotech Corporation Information
11.19.2 Nuron Biotech Description and Business Overview
11.19.3 Nuron Biotech Sales, Revenue and Gross Margin (2015-2020)
11.19.4 Nuron Biotech Products Offered
11.19.5 Nuron Biotech Related Developments
11.20 Biogen
11.20.1 Biogen Corporation Information
11.20.2 Biogen Description and Business Overview
11.20.3 Biogen Sales, Revenue and Gross Margin (2015-2020)
11.20.4 Biogen Products Offered
11.20.5 Biogen Related Developments
11.21 Valneva Austria
11.21.1 Valneva Austria Corporation Information
11.21.2 Valneva Austria Description and Business Overview
11.21.3 Valneva Austria Sales, Revenue and Gross Margin (2015-2020)
11.21.4 Valneva Austria Products Offered
11.21.5 Valneva Austria Related Developments
11.22 Sinovac
11.22.1 Sinovac Corporation Information
11.22.2 Sinovac Description and Business Overview
11.22.3 Sinovac Sales, Revenue and Gross Margin (2015-2020)
11.22.4 Sinovac Products Offered
11.22.5 Sinovac Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pneumococcal Vaccines Market Estimates and Projections by Region
12.1.1 Global Pneumococcal Vaccines Sales Forecast by Regions 2021-2026
12.1.2 Global Pneumococcal Vaccines Revenue Forecast by Regions 2021-2026
12.2 North America Pneumococcal Vaccines Market Size Forecast (2021-2026)
12.2.1 North America: Pneumococcal Vaccines Sales Forecast (2021-2026)
12.2.2 North America: Pneumococcal Vaccines Revenue Forecast (2021-2026)
12.2.3 North America: Pneumococcal Vaccines Market Size Forecast by Country (2021-2026)
12.3 Europe Pneumococcal Vaccines Market Size Forecast (2021-2026)
12.3.1 Europe: Pneumococcal Vaccines Sales Forecast (2021-2026)
12.3.2 Europe: Pneumococcal Vaccines Revenue Forecast (2021-2026)
12.3.3 Europe: Pneumococcal Vaccines Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pneumococcal Vaccines Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pneumococcal Vaccines Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pneumococcal Vaccines Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pneumococcal Vaccines Market Size Forecast by Region (2021-2026)
12.5 Latin America Pneumococcal Vaccines Market Size Forecast (2021-2026)
12.5.1 Latin America: Pneumococcal Vaccines Sales Forecast (2021-2026)
12.5.2 Latin America: Pneumococcal Vaccines Revenue Forecast (2021-2026)
12.5.3 Latin America: Pneumococcal Vaccines Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pneumococcal Vaccines Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pneumococcal Vaccines Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pneumococcal Vaccines Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pneumococcal Vaccines Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pneumococcal Vaccines Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pneumococcal Vaccines Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Pneumococcal Vaccines Market Segments
Table 2. Ranking of Global Top Pneumococcal Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pneumococcal Vaccines Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of PPSV 23
Table 5. Major Manufacturers of PCV 7/13
Table 6. Major Manufacturers of PCV 10
Table 7. Global Pneumococcal Vaccines Market Size Growth Rate by Application 2020-2026 (K Units)
Table 8. Global Pneumococcal Vaccines Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 9. Global Pneumococcal Vaccines Sales by Regions 2015-2020 (K Units)
Table 10. Global Pneumococcal Vaccines Sales Market Share by Regions (2015-2020)
Table 11. Global Pneumococcal Vaccines Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Pneumococcal Vaccines Sales by Manufacturers (2015-2020) (K Units)
Table 13. Global Pneumococcal Vaccines Sales Share by Manufacturers (2015-2020)
Table 14. Global Pneumococcal Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Pneumococcal Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pneumococcal Vaccines as of 2019)
Table 16. Pneumococcal Vaccines Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Pneumococcal Vaccines Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Pneumococcal Vaccines Price (2015-2020) (USD/Unit)
Table 19. Pneumococcal Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Pneumococcal Vaccines Product Type
Table 21. Date of International Manufacturers Enter into Pneumococcal Vaccines Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Pneumococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 24. Global Pneumococcal Vaccines Sales Share by Type (2015-2020)
Table 25. Global Pneumococcal Vaccines Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Pneumococcal Vaccines Revenue Share by Type (2015-2020)
Table 27. Pneumococcal Vaccines Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 28. Global Pneumococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 29. Global Pneumococcal Vaccines Sales Share by Application (2015-2020)
Table 30. North America Pneumococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 31. North America Pneumococcal Vaccines Sales Market Share by Country (2015-2020)
Table 32. North America Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Pneumococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 34. North America Pneumococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 35. North America Pneumococcal Vaccines Sales Market Share by Type (2015-2020)
Table 36. North America Pneumococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 37. North America Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
Table 38. Europe Pneumococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 39. Europe Pneumococcal Vaccines Sales Market Share by Country (2015-2020)
Table 40. Europe Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Pneumococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 42. Europe Pneumococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 43. Europe Pneumococcal Vaccines Sales Market Share by Type (2015-2020)
Table 44. Europe Pneumococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 45. Europe Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Pneumococcal Vaccines Sales by Region (2015-2020) (K Units)
Table 47. Asia Pacific Pneumococcal Vaccines Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Pneumococcal Vaccines Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Pneumococcal Vaccines Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Pneumococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 51. Asia Pacific Pneumococcal Vaccines Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Pneumococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 53. Asia Pacific Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
Table 54. Latin America Pneumococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 55. Latin America Pneumococcal Vaccines Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Pneumococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 58. Latin America Pneumococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 59. Latin America Pneumococcal Vaccines Sales Market Share by Type (2015-2020)
Table 60. Latin America Pneumococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 61. Latin America Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Pneumococcal Vaccines Sales by Country (2015-2020) (K Units)
Table 63. Middle East and Africa Pneumococcal Vaccines Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Pneumococcal Vaccines Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Pneumococcal Vaccines Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Pneumococcal Vaccines Sales by Type (2015-2020) (K Units)
Table 67. Middle East and Africa Pneumococcal Vaccines Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Pneumococcal Vaccines Sales by Application (2015-2020) (K Units)
Table 69. Middle East and Africa Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Major Businesses
Table 72. Pfizer Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 73. Pfizer Product
Table 74. Pfizer Recent Development
Table 75. Sanofi Corporation Information
Table 76. Sanofi Description and Major Businesses
Table 77. Sanofi Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Sanofi Product
Table 79. Sanofi Recent Development
Table 80. GSK Corporation Information
Table 81. GSK Description and Major Businesses
Table 82. GSK Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. GSK Product
Table 84. GSK Recent Development
Table 85. Merck Corporation Information
Table 86. Merck Description and Major Businesses
Table 87. Merck Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Merck Product
Table 89. Merck Recent Development
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Major Businesses
Table 92. Eli Lilly Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Eli Lilly Product
Table 94. Eli Lilly Recent Development
Table 95. AstraZeneca Corporation Information
Table 96. AstraZeneca Description and Major Businesses
Table 97. AstraZeneca Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. AstraZeneca Product
Table 99. AstraZeneca Recent Development
Table 100. Abera Corporation Information
Table 101. Abera Description and Major Businesses
Table 102. Abera Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Abera Product
Table 104. Abera Recent Development
Table 105. S K Chemicals Corporation Information
Table 106. S K Chemicals Description and Major Businesses
Table 107. S K Chemicals Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. S K Chemicals Product
Table 109. S K Chemicals Recent Development
Table 110. Beijing Minhai Biotechnology Corporation Information
Table 111. Beijing Minhai Biotechnology Description and Major Businesses
Table 112. Beijing Minhai Biotechnology Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Beijing Minhai Biotechnology Product
Table 114. Beijing Minhai Biotechnology Recent Development
Table 115. Baxter Corporation Information
Table 116. Baxter Description and Major Businesses
Table 117. Baxter Pneumococcal Vaccines Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Baxter Product
Table 119. Baxter Recent Development
Table 120. Biken Corporation Information
Table 121. Biken Description and Major Businesses
Table 122. Biken Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Biken Product
Table 124. Biken Recent Development
Table 125. Celgene Corporation Corporation Information
Table 126. Celgene Corporation Description and Major Businesses
Table 127. Celgene Corporation Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Celgene Corporation Product
Table 129. Celgene Corporation Recent Development
Table 130. Panacea Biotec Corporation Information
Table 131. Panacea Biotec Description and Major Businesses
Table 132. Panacea Biotec Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Panacea Biotec Product
Table 134. Panacea Biotec Recent Development
Table 135. Serum Institute of India Corporation Information
Table 136. Serum Institute of India Description and Major Businesses
Table 137. Serum Institute of India Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Serum Institute of India Product
Table 139. Serum Institute of India Recent Development
Table 140. Genentech Corporation Information
Table 141. Genentech Description and Major Businesses
Table 142. Genentech Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Genentech Product
Table 144. Genentech Recent Development
Table 145. Genocea Biosciences Corporation Information
Table 146. Genocea Biosciences Description and Major Businesses
Table 147. Genocea Biosciences Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Genocea Biosciences Product
Table 149. Genocea Biosciences Recent Development
Table 150. ImmunoBiology Corporation Information
Table 151. ImmunoBiology Description and Major Businesses
Table 152. ImmunoBiology Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. ImmunoBiology Product
Table 154. ImmunoBiology Recent Development
Table 155. Lupin Corporation Information
Table 156. Lupin Description and Major Businesses
Table 157. Lupin Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Lupin Product
Table 159. Lupin Recent Development
Table 160. Nuron Biotech Corporation Information
Table 161. Nuron Biotech Description and Major Businesses
Table 162. Nuron Biotech Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 163. Nuron Biotech Product
Table 164. Nuron Biotech Recent Development
Table 165. Biogen Corporation Information
Table 166. Biogen Description and Major Businesses
Table 167. Biogen Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 168. Biogen Product
Table 169. Biogen Recent Development
Table 170. Valneva Austria Corporation Information
Table 171. Valneva Austria Description and Major Businesses
Table 172. Valneva Austria Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 173. Valneva Austria Product
Table 174. Valneva Austria Recent Development
Table 175. Sinovac Corporation Information
Table 176. Sinovac Description and Major Businesses
Table 177. Sinovac Pneumococcal Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 178. Sinovac Product
Table 179. Sinovac Recent Development
Table 180. Global Pneumococcal Vaccines Sales Forecast by Regions (2021-2026) (K Units)
Table 181. Global Pneumococcal Vaccines Sales Market Share Forecast by Regions (2021-2026)
Table 182. Global Pneumococcal Vaccines Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 183. Global Pneumococcal Vaccines Revenue Market Share Forecast by Regions (2021-2026)
Table 184. North America: Pneumococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 185. North America: Pneumococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 186. Europe: Pneumococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 187. Europe: Pneumococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 188. Asia Pacific: Pneumococcal Vaccines Sales Forecast by Region (2021-2026) (K Units)
Table 189. Asia Pacific: Pneumococcal Vaccines Revenue Forecast by Region (2021-2026) (US$ Million)
Table 190. Latin America: Pneumococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 191. Latin America: Pneumococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 192. Middle East and Africa: Pneumococcal Vaccines Sales Forecast by Country (2021-2026) (K Units)
Table 193. Middle East and Africa: Pneumococcal Vaccines Revenue Forecast by Country (2021-2026) (US$ Million)
Table 194. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 195. Key Challenges
Table 196. Market Risks
Table 197. Main Points Interviewed from Key Pneumococcal Vaccines Players
Table 198. Pneumococcal Vaccines Customers List
Table 199. Pneumococcal Vaccines Distributors List
Table 200. Research Programs/Design for This Report
Table 201. Key Data Information from Secondary Sources
Table 202. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumococcal Vaccines Product Picture
Figure 2. Global Pneumococcal Vaccines Sales Market Share by Type in 2020 & 2026
Figure 3. PPSV 23 Product Picture
Figure 4. PCV 7/13 Product Picture
Figure 5. PCV 10 Product Picture
Figure 6. Global Pneumococcal Vaccines Sales Market Share by Application in 2020 & 2026
Figure 7. For Infants
Figure 8. For Children (2-10)
Figure 9. For Person (10-64)
Figure 10. For The Old (Above 65)
Figure 11. Pneumococcal Vaccines Report Years Considered
Figure 12. Global Pneumococcal Vaccines Market Size 2015-2026 (US$ Million)
Figure 13. Global Pneumococcal Vaccines Sales 2015-2026 (K Units)
Figure 14. Global Pneumococcal Vaccines Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Pneumococcal Vaccines Sales Market Share by Region (2015-2020)
Figure 16. Global Pneumococcal Vaccines Sales Market Share by Region in 2019
Figure 17. Global Pneumococcal Vaccines Revenue Market Share by Region (2015-2020)
Figure 18. Global Pneumococcal Vaccines Revenue Market Share by Region in 2019
Figure 19. Global Pneumococcal Vaccines Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Pneumococcal Vaccines Revenue in 2019
Figure 21. Pneumococcal Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Pneumococcal Vaccines Sales Market Share by Type (2015-2020)
Figure 23. Global Pneumococcal Vaccines Sales Market Share by Type in 2019
Figure 24. Global Pneumococcal Vaccines Revenue Market Share by Type (2015-2020)
Figure 25. Global Pneumococcal Vaccines Revenue Market Share by Type in 2019
Figure 26. Global Pneumococcal Vaccines Market Share by Price Range (2015-2020)
Figure 27. Global Pneumococcal Vaccines Sales Market Share by Application (2015-2020)
Figure 28. Global Pneumococcal Vaccines Sales Market Share by Application in 2019
Figure 29. Global Pneumococcal Vaccines Revenue Market Share by Application (2015-2020)
Figure 30. Global Pneumococcal Vaccines Revenue Market Share by Application in 2019
Figure 31. North America Pneumococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 32. North America Pneumococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Pneumococcal Vaccines Sales Market Share by Country in 2019
Figure 34. North America Pneumococcal Vaccines Revenue Market Share by Country in 2019
Figure 35. U.S. Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 36. U.S. Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 38. Canada Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Pneumococcal Vaccines Market Share by Type in 2019
Figure 40. North America Pneumococcal Vaccines Market Share by Application in 2019
Figure 41. Europe Pneumococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 42. Europe Pneumococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Pneumococcal Vaccines Sales Market Share by Country in 2019
Figure 44. Europe Pneumococcal Vaccines Revenue Market Share by Country in 2019
Figure 45. Germany Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 46. Germany Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 48. France Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 50. U.K. Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 52. Italy Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 54. Russia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Pneumococcal Vaccines Market Share by Type in 2019
Figure 56. Europe Pneumococcal Vaccines Market Share by Application in 2019
Figure 57. Asia Pacific Pneumococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 58. Asia Pacific Pneumococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Pneumococcal Vaccines Sales Market Share by Region in 2019
Figure 60. Asia Pacific Pneumococcal Vaccines Revenue Market Share by Region in 2019
Figure 61. China Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 62. China Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 64. Japan Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 66. South Korea Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 68. India Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 70. Australia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 72. Taiwan Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 74. Indonesia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 76. Thailand Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 78. Malaysia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 80. Philippines Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 82. Vietnam Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Pneumococcal Vaccines Market Share by Type in 2019
Figure 84. Asia Pacific Pneumococcal Vaccines Market Share by Application in 2019
Figure 85. Latin America Pneumococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 86. Latin America Pneumococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Pneumococcal Vaccines Sales Market Share by Country in 2019
Figure 88. Latin America Pneumococcal Vaccines Revenue Market Share by Country in 2019
Figure 89. Mexico Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 90. Mexico Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 92. Brazil Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 94. Argentina Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Pneumococcal Vaccines Market Share by Type in 2019
Figure 96. Latin America Pneumococcal Vaccines Market Share by Application in 2019
Figure 97. Middle East and Africa Pneumococcal Vaccines Sales Growth Rate 2015-2020 (K Units)
Figure 98. Middle East and Africa Pneumococcal Vaccines Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Pneumococcal Vaccines Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Pneumococcal Vaccines Revenue Market Share by Country in 2019
Figure 101. Turkey Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 102. Turkey Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 104. Saudi Arabia Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Pneumococcal Vaccines Sales Growth Rate (2015-2020) (K Units)
Figure 106. U.A.E Pneumococcal Vaccines Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Pneumococcal Vaccines Market Share by Type in 2019
Figure 108. Middle East and Africa Pneumococcal Vaccines Market Share by Application in 2019
Figure 109. North America Pneumococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 110. North America Pneumococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Pneumococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 112. Europe Pneumococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Pneumococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 114. Asia Pacific Pneumococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Pneumococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 116. Latin America Pneumococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Pneumococcal Vaccines Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 118. Middle East and Africa Pneumococcal Vaccines Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
H1N1ワクチンの世界市場（～2026年） A vaccine is a biological preparation consisting of an agent that closely resembles a disease-causing microorganism and is made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The global H1N1 vaccination market is anticipated to boost in the focus period due …- ワクチンデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vaccines Delivery Scope and Market Size Vaccines Delivery market is segmented b…
- 予防的B型肝炎ウイルスワクチンの世界市場（～2026年） The main objective of hepatitis B immunization strategies is to prevent chronic hepatitis B virus infection and its serious consequences, including liver cirrhosis and hepatocellular cancer. The increasing prevalence and incidence of hepatitis B infection is the dominant factor of driving the growth…
- 細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…
- ワクチン・予防接種の世界市場（～2026年） Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccin…